Code
01J17707
Duration
01 January 2007 → 31 October 2011
Funding
Regional and community funding: Special Research Fund
Promotor
Research disciplines
-
Medical and health sciences
- Medicinal products
-
Engineering and technology
- Biomaterials engineering
- Biological system engineering
- Biomaterials engineering
- Biomechanical engineering
- Other (bio)medical engineering
- Environmental engineering and biotechnology
- Industrial biotechnology
- Other biotechnology, bio-engineering and biosystem engineering
Keywords
biomolecular engineering
radio-immunotherapy
xvB5
Project description
The purpose of the proposal encloses the development of recombinant, humanised anti-xvB5 antibody fragments adapated for radio-immunotherapy and radio-diagnosis in the treatment of non-small cell lung cancer. The biotechnological engineering, the labelling with radio-isotopes and the in vitro and in vivo evaluation in an experimental animal model will be investigated in the research project.